OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics, a leading US-based contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, today announced the expansion of its upstream process development offerings with the addition of perfusion capabilities. The new capability provides biopharmaceutical companies with an additional process development option alongside traditional fed-batch manufacturing, enabling Cytovance to better support programs requiring hi
OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics, a leading US-based contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, today announced the expansion of its upstream process development offerings with the addition of perfusion capabilities. The new capability provides biopharmaceutical companies with an additional process development option alongside traditional fed-batch manufacturing, enabling Cytovance to better support programs requiring hi
- Published
- Jul 15, 2026
- Updated
- Jul 15, 2026
- Source
- Businesswire
- Category
- Health
- Read time
- 1 min
Key facts
Why this matters locally
This health story matters locally because it may affect readers, businesses, commuters, families, or public services in British Columbia.
Local impact
BC Post links this item to British Columbia coverage so readers can follow related city updates, weather, traffic, events, and category news in one place.
Timeline
Source and credit
BC Post may summarize, organize, and add local context for reader clarity. Original reporting remains with the listed publisher.